Drug Discovery

topic on 10 shows · 24 statements across 19 episodes

the Y Combinator Startup Podcast Innovators & Investors Latent Space No Priors the MAD Podcast the a16z Podcast Big Technology All-In TBPN 20VC

24 statements about Drug Discovery, every show

a16z Insight
Sinofsky: Drug discovery bottleneck is clinical safety testing, not candidate generation
“This is not a magic to discover drugs, because the hard part of drugs has always been candidates. Not candidates. It's always been efficacy and safety. The candidates have, since the eighties, have been able to develop more than we could test. It's human patie…”
Steven Sinofsky Aug 25, 2026 ▶ 59:29 How AI Changes the Economics of Innovation
Feinberg: Drug discovery and design is AI's highest-leverage application in healthcare
“Our contention is that the highest leverage application of artificial intelligence Is the drug discovery and drug design process.”
Evan Feinberg Jun 30, 2026 ▶ 27:36 🔬 "The Most Innovative Diffusion Research Is Happening in Drug Discovery, Not Image Generation"
Edunov: Predicting ADMET properties is as critical as protein structure prediction
“Predicting all of those properties is also just as important as, or maybe even more important than predicting the crystal structure itself.”
Sergei Yudinov Jun 30, 2026 ▶ 37:45 🔬 "The Most Innovative Diffusion Research Is Happening in Drug Discovery, Not Image Generation"
Feinberg: Drug candidates must pass over 30 distinct assay properties
“I would say there's over 30 or so assays, each of which you could imagine if you're a neural net person, like a multitask neural network or multi-head, it's got to predict over 30, you know, three dozen-ish properties, each of which, if it's in the wrong range…”
Evan Feinberg Jun 30, 2026 ▶ 1:00:36 🔬 "The Most Innovative Diffusion Research Is Happening in Drug Discovery, Not Image Generation"
Feinberg: High-throughput screening exhibits a shockingly low R-squared to actual synthesis
“The reality is that the translation of high throughput screens, whether it's Dell, DNA encoded libraries, or more traditional screens, the R-squared of those predictions to, like, the actual business of resynthesizing a molecule de novo and doing a Low through…”
Evan Feinberg Jun 30, 2026 ▶ 1:18:36 🔬 "The Most Innovative Diffusion Research Is Happening in Drug Discovery, Not Image Generation"
Y COMBINATOR Prediction Not checkable as stated
Hassabis: Almost Every Future Drug Will Use AlphaFold During Discovery
“I was told by some of my, you know, pharma executive friends that, you know, almost every drug Discovered from now on will have used alpha fold at some point in it, in the drug discovery process.”
Demis Hassabis Apr 29, 2026 ▶ 29:34 Demis Hassabis: Agents, AGI & The Next Big Scientific Breakthrough · Y Combinator
INNOVATORS & INVESTORS Assertion Supported
Doronichev: Early drug discovery represents only $100B of the $2T pharma market
“Pharma is a two trillion dollar industry. Of that trillion dollar, only a hundred billion dollars is in drug discovery, so this early stage. A hundred bill out of two trillion is a tiny fraction”
Andrey Doronichev Apr 14, 2026 ▶ 27:48 Driving Efficiency in Biotech Research with Andrey Doronichev of BIOPTIC | The Innovators & Investors Podcast
TBPN Assertion Supported
Jon Ma: Lack of target validation is top reason for drug failure
“Since the hardest part of drug discovery, whether in humans or dogs, is target validation, the lack of which leads to a lack of efficacy. The number one reason for drug failure.”
Jon Ma Mar 16, 2026 ▶ 16:56 AI vs. Dog Cancer, Timothée Chalamet Under Fire, ‘Agents Over Bubbles' | Diet TBPN
Hodak: Humanity is fundamentally ineffective at pharmaceutical drug discovery
“Humanity isn't very good at drug discovery. Every now and then you kind of find a thing. It's amazing. Like you find a GLP one or you find like there's every, like there's a handful of drugs that are, we were lucky to find, but it's much more common that you s…”
Max Hodak Mar 9, 2026 ▶ 13:53 The Future Of Brain-Computer Interfaces · Y Combinator
BIG TECHNOLOGY Prediction Not checkable as stated
Hassabis: Almost every future drug discovered will probably use AlphaFold
“I think in future Almost every single drug that's discovered from now on will probably have used AlphaFold at some point in that process, which is, you know, amazing for us, and, you know, really, that's what we do, all the work we do for.”
Demis Hassabis Jan 23, 2026 ▶ 30:58 Google DeepMind CEO Demis Hassabis: AI's Next Breakthroughs, AGI Timeline, Google's AI Glasses Bet
NO PRIORS Prediction Not checkable as stated
Wickramasekara: AI in scientific discovery will focus on augmentation over autonomy next 1-2 years
“While I would love for that to happen, and I'm maybe more optimistic on a longer time scale, we will get there. I think in the short term, I'm next one to two years, which, you know, already feels like an eternity in AI time. I'm a little bit more bullish on s…”
Sajith Wickramasekara Nov 13, 2025 ▶ 19:03 No Priors Ep. 140 | With Benchling Co-Founder and CEO Sajith Wickramasekara
a16z Insight
Hoffman: Predictive AI for drug discovery only needs 1% accuracy
“Simply doing prediction and getting that prediction right, and by the way, it doesn't have to be right a hundred percent of time, it has to be right, like, one percent of the time, because you can validate the other 99% were it right, and then finding that one…”
Reid Hoffman Oct 20, 2025 ▶ 6:57 Reid Hoffman on AI, Consciousness, and the Future of Labor
ALL-IN Prediction Not checkable as stated
Hassabis predicts AI could shorten drug discovery to days within a decade
“I think we could reduce down drug discovery from taking years, sometimes a decade to do, down to maybe weeks, or even days over the next 10 years.”
Demis Hassabis Sep 12, 2025 ▶ 25:17 Inside Google DeepMind: AGI, Robotics, & World Models Explained - Demis Hassabis
NO PRIORS Prediction Not checkable as stated
Yu: Virtual cell models will directly design disease-reversing drugs
“A big part of our future vision and roadmap is that we think there will be a moment where from a virtual cell model, a drug is spit out, and basically the drug will actually cause a healthy disease cell to become a healthy cell again.”
Johnny Yu Feb 25, 2025 ▶ 37:03 No Priors Ep. 103 | With Vevo Therapeutics and the Arc Institute
20VC Prediction Open · timeframe Dec 2029
Hoffman: Quantum computing will aid drug discovery long before breaking encryption
“Look, we'll have to figure that out because that'll be an issue once we get to what is, you know, somewhere maybe minimum 2000 or 5000 logical quantum bits, qubits. So that's at 2000 to 5000 or more is when you get into the encryption issues. I'd call it a 150…”
Reid Hoffman Dec 16, 2024 ▶ 31:18 Reid Hoffman, LinkedIn & Paypal Founder: Trump Administration, Elon Musk and DOGE | E1239 · 20VC with Harry Stebbings
a16z Assertion Not checkable as stated
Bowen Liu calls labeled data scarcity the core bottleneck in scientific AI
“Yeah, I think you touched on, like, probably the core problem of, like, you know, ML applied to science. While we have a lot of, like, unlabeled data, like, there's just not that much label data out there. And a lot of it is because, like, it's very experiment…”
Bowen Liu Oct 3, 2024 ▶ 7:09 AI at the Intersection of Bio | Vijay Pande, Surya Ganguli & Bowen Liu
a16z Assertion Not checkable as stated
Liu: 100 active compounds is a drug candidate but tiny for ML
“Usually in a drug discovery project, you know, if you have a hundred actives, you should be close to a drug, but a hundred data points is, like, tiny for machine learning, right?”
Bowen Liu Oct 3, 2024 ▶ 7:28 AI at the Intersection of Bio | Vijay Pande, Surya Ganguli & Bowen Liu
NO PRIORS Assertion Supported
Koller: 95% of all drug discovery programs fail
“If you look at the actual numbers of what makes drug discovery so expensive, it is the fact that 95% of drug programs fail. They just do not succeed.”
Daphne Koller May 19, 2023 ▶ 12:38 No Priors Ep. 6 | With Daphne Koller from Insitro
NO PRIORS Disclosure
Koller: Insitro uses agile for platform biology, but not drug discovery projects
“We have product managers who do scrums and do you know, these agile planning processes, and we apply that also to our platform development, even on the biology side. But at the same time, you know, drug discovery projects, which are years long, you don't do sc…”
Daphne Koller May 19, 2023 ▶ 38:28 No Priors Ep. 6 | With Daphne Koller from Insitro
a16z Insight
Bahcall: Market projections kill early-stage innovation, especially in drug discovery
“Nothing kills a great idea faster and has been more of a disaster to innovation, certainly in my industry in drug discovery, than the idea of market projections.”
Safi Bahcall Apr 1, 2019 ▶ 11:20 a16z Podcast | Incenting Innovation Inside, Loonshots to Moonshots
a16z Prediction Not checkable as stated
Genetic variation databases will transform drug discovery and optimization
“Moreover, we can now see how building a large bank of human genetics variations will transform our understanding on optimizing of drug discovery and response, both for understanding side effects and toxicity, as well as making better drugs and going after new …”
Vijay Pande Jan 2, 2019 ▶ 0:40 a16z Podcast | The Genetics Of Drug Delivery
MAD Assertion Supported
Drug discovery return on investment is exponentially decreasing
“The return on investment for drug discovery is exponentially decreasing.”
Jerome Pesenti Oct 26, 2017 ▶ 0:37 Using AI to Accelerate Drug Discovery // Jerome Pesenti, BenevolentAI (FirstMark's Data Driven)
Iorns: Early drug discovery phase suffers from industry-wide underinvestment
“Particularly the earliest phase of discovery, that is an area where there's significant underinvestment just generally in the industry.”
Elizabeth Iorns Sep 13, 2017 ▶ 9:14 Elizabeth Iorns on Biotech Companies in YC · Y Combinator
MAD Insight
Wickramasekara: Antibody drug discovery has no fixed deterministic formula
“For most antibody research. The discovery process itself is a work in process. There's no formula for spitting out a drug by going through some set of steps that's going to work.”
Sajith Wickramasekara Feb 3, 2017 ▶ 9:39 Drug Discovery as a Data Problem // Sajith Wickramasekara, Benchling (FirstMark's Data Driven)

← every entity, every show

Made with StarZero

Turn any episode into a week of clips.

This entire site, thousands of episodes across every show transcribed, diarized, checked and made playable, runs on the StarZero media pipeline. Drop in your own episode and the podcast clipper finds the moments worth sharing, cuts them, captions them, and reframes them for every feed.